Breaking News

Solvias CoE for Biologics & Novel Modalities Becomes cGMP Ready

Enables the RTP facility to deliver fully compliant analytical testing and release services for advanced therapies from early-stage development through commercialization.

Author Image

By: Charlie Sternberg

Associate Editor

Solvias, a global provider of chemistry, manufacturing, and controls (CMC) analysis, has announced that its recently opened Center of Excellence for biologics and novel modalities in Research Triangle Park (RTP), North Carolina, is now Current Good Manufacturing Practice (cGMP) ready. This milestone enables the RTP facility to deliver fully compliant analytical testing and release services for advanced therapies from early-stage development through commercialization. Archie Cullen, CEO of ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters